AngioDynamics (Albany, New York) said it has received clearance for its BioFlo Port with Endexo technology, a device designed to reduce the accumulation of cather-related thrombus on, and in, the port catheter. The company said the clearance of the BioFlo Port with Endexo technology marks the second U.S. clearance of a product line developed with BioFlo's technology.